mHealth Intelligence April 4, 2024
Stakeholders are urging the agency to permanently allow virtual prescriptions of controlled substances without in-person exams well before the flexibility expires.
More than 200 virtual care stakeholders, including trade associations, healthcare providers, and telehealth companies, have signed a letter urging the United States Drug Enforcement Administration (DEA) to release a revised proposed rule allowing virtual prescribing of controlled substances soon.
The letter states that a revised rule permanently allowing controlled substances to be prescribed via telehealth without a prior in-person examination “is crucial for access to mental health, substance use disorder, and other telehealth care.”
Before the COVID-19 pandemic, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 required healthcare practitioners to conduct an in-person medical evaluation before allowing...
Today's Sponsors
Today's Sponsor